webinar register page

Webinar banner
Update on Adaptimmune’s SURPASS Family of Trials
On the first day of ESMO, September 9th, we will host a live virtual event to discuss data from the Phase 1 SURPASS trial and outline plans for our SURPASS family of trials.

In addition to members of our management team, Dr. Kathleen Moore will provide her perspective on the potential of cell therapy in solid tumors – including her experiences with patients with ovarian cancer treated in our Phase 1 SURPASS trial. Dr. Moore is an Associate Professor of Gynecologic Oncology at the University of Oklahoma College of Medicine and a member of the Gynecologic Oncology Group Foundation Inc. investigator council.

The presentation will be followed by a live Q&A session.

Sep 9, 2022 08:00 AM in Eastern Time (US and Canada)

Adaptimmune logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Adaptimmune Events US.